A general description for Chinese medicine in treating premature ovarian failure

Jing Lin; Xue-lian Li; Hui Song; Qian Li; Ming-yan Wang; Xue-min Qiu; Da-jin Li; Ling Wang

doi:10.1007/s11655-016-2642-7

Your Location：

Home >

Browse articles >

A general description for Chinese medicine in treating premature ovarian failure

OriginalPaper | Updated：2021-08-27

- A general description for Chinese medicine in treating premature ovarian failure
- A general description for Chinese medicine in treating premature ovarian failure
- 中国结合医学杂志（英文版） 2017年23卷第2期页码：91-97
- Affiliations：
  
  1. Laboratory for Reproductive Immunology, Hospital and Institute of Obstetrics and Gynecology, Institutes of Biomedical Sciences (IBS), Fudan University Shanghai Medical College,Shanghai,China
  2. Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases,Shanghai,China
  3. The Academy of Integrative Medicine of Fudan University,Shanghai,China
- Author bio：
- Funds：
  
  Supported by the National Natural Science Foundation of China (No. 31571196, No. 30801502, No. 81401171), the Municipal Science and Technology Commission of Shanghai, China (Medical Guidance Technology Project, No. 15401932200), a FY2008 JSPS Postdoctoral Fellowship for Foreign Researchers (No. P08471), the Shanghai Pujiang Program (No. 11PJ1401900), the Development Project of Shanghai Peak Disciplines-Integrated Chinese and Western Medicine (No. 20150407)
- DOI：10.1007/s11655-016-2642-7
  中图分类号：
- 纸质出版日期：2017，
  
  网络出版日期：2017-3-7，
Scan for full text
Lin, J., Li, Xl., Song, H. et al. A general description for Chinese medicine in treating premature ovarian failure., Chin. J. Integr. Med. 23, 91–97 (2017). https://doi.org/10.1007/s11655-016-2642-7

Jing Lin, Xue-lian Li, Hui Song, et al. A general description for Chinese medicine in treating premature ovarian failure[J]. Chinese Journal of Integrative Medicine, 2017,23(2):91-97.
Lin, J., Li, Xl., Song, H. et al. A general description for Chinese medicine in treating premature ovarian failure., Chin. J. Integr. Med. 23, 91–97 (2017). https://doi.org/10.1007/s11655-016-2642-7 DOI：

Jing Lin, Xue-lian Li, Hui Song, et al. A general description for Chinese medicine in treating premature ovarian failure[J]. Chinese Journal of Integrative Medicine, 2017,23(2):91-97. DOI： 10.1007/s11655-016-2642-7.

摘要

Premature ovarian failure (POF) is a kind of gynecological disease that causes amenorrhea

infertility

menopause and urogenital symptoms. Currently hormone replacement therapy (HRT) is the most popular choice for women with POF to get rid of menopausal syndrome. However

as the popularization of Chinese herbs made Chinese medicine (CM) shine new lights

physicians are able to treat POF with both meno-herbs and integrated therapy. HRT has its own indications and contraindications. For example

unexplained vaginal bleeding

acute liver damage

liver dysfunction

vascular embolization

and breast cancer are all contraindications of HRT

and CM is taken by more physicians as an adjuvant therapy. This review

including a range of common Chinese herbs and formulations according to the existing literature

provides a general description of CM treating POF from the aspects of mechanisms and clinical application. It also highlights acupuncture as a unique physiotherapy for POF. Although the validity of CM has been supported by the evidence of many preclinical trials

clinical trials and meta-analysis

the adverse events with CM therapy still exist and no guarantee has been made for its safety. This review concludes the updated information for CM treating POF contributing to further studies.

Abstract

Premature ovarian failure (POF) is a kind of gynecological disease that causes amenorrhea

infertility

menopause and urogenital symptoms. Currently hormone replacement therapy (HRT) is the most popular choice for women with POF to get rid of menopausal syndrome. However

as the popularization of Chinese herbs made Chinese medicine (CM) shine new lights

physicians are able to treat POF with both meno-herbs and integrated therapy. HRT has its own indications and contraindications. For example

unexplained vaginal bleeding

acute liver damage

liver dysfunction

vascular embolization

and breast cancer are all contraindications of HRT

and CM is taken by more physicians as an adjuvant therapy. This review

including a range of common Chinese herbs and formulations according to the existing literature

clinical trials and meta-analysis

the adverse events with CM therapy still exist and no guarantee has been made for its safety. This review concludes the updated information for CM treating POF contributing to further studies.

关键词

Chinese MedicineChinese Herbal MedicinePremature Ovarian FailureInfertilityacupuncture

Keywords

Chinese MedicineChinese Herbal MedicinePremature Ovarian FailureInfertilityacupuncture

references

Pal L, Santoro N. Premature ovarian failure (POF): discordance between somatic and reproductive aging. Ageing Res Rev 2002;1:413–423.

Goswami D, Conway GS. Premature ovarian failure. Hum Reprod Update 2005;11:391–410.

Coulam CB, Adamson SC, Annegers JF. Incidence of premature ovarian failure. Obstet Gynecol 1986;67:604–606.

Jin M, Yu YQ, Huang HF. An update on primary ovarian insufficiency. Sci China Life Sci 2012;55:677–686.

Lozano R, Rosero CA, Hagerman RJ. Fragile X spectrum disorders. Intractable Rare Dis Res 2014;3:134–146.

Yrigollen CM, Sweha S, Durbin-Johnson B, Zhou L, Berry-Kravis E, Fernandez-Carvajal I, et al. Distribution of AGG interruption patterns within nine world populations. Intractable Rare Dis Res 2014;3:153–161.

Nelson LM. Clinical practice. Primary ovarian insufficiency. N Engl J Med 2009;360:606–614.

Stefanick ML. Estrogens and progestins: background and history, trends in use, and guidelines and regimens approved by the US Food and Drug Administration. Am J Med 2005;118:64S–73S.

Beral V, Bull D, Reeves G. Endometrial cancer and hormone-replacement therapy in the Million Women Study. Lancet 2005;365:1543–1551.

Grady D, Gebretsadik T, Kerlikowske K, Ernster V, Petitti D. Hormone replacement therapy and endometrial cancer risk: a meta-analysis. Obstet Gynecol 1995;85:304–313.

Lee AW, Ness RB, Roman LD, Terry KL, Schildkraut JM, Chang-Claude J, et al. Association between menopausal estrogen-only therapy and ovarian carcinoma risk. Obstet Gynecol 2016;127:828–836.

Xie X, Gou WL, eds. Obstetrics and gynecology. China: People's Medical Publishing House; 2013.

UK NCCF. Menopause: full guideline. London: National Institute for Health and Care Excellence;2015.

Qi F, Li A, Inagaki Y, Gao J, Li J, Kokudo N, et al. Chinese herbal medicines as adjuvant treatment during chemo-or radio-therapy for cancer. Biosci Trends 2010;4:297–307.

Qi F, Zhao L, Zhou A, Zhang B, Li A, Wang Z, et al. The advantages of using traditional Chinese medicine as an adjunctive therapy in the whole course of cancer treatment instead of only terminal stage of cancer. Biosci Trends 2015;9:16–34.

Xia J, Chen J, Zhang Z, Song P, Tang W, Kokudo N. A map describing the association between effective components of traditional Chinese medicine and signaling pathways in cancer cells in vitro and in vivo. Drug Discov Ther 2014;8:139–153.

Li Y, Yang W, Zhu Q, Yang J, Wang Z. Protective effects on vascular endothelial cell in N'-nitro-L-arginine (L-NNA)-induced hypertensive rats from the combination of effective components of Uncaria rhynchophylla and Semen Raphani. Biosci Trends 2015;9:237–244.

Qin DN, She BR, She YC. Effects of flavonoids of Semen Cuscutae on reproductive function of animals. Tradit Chin Drug Res Pharmacol (Chin) 2000;11:349–351.

Du HL, Duan YC, Song CM. Effects of Bushen Tiaojing Formula on the receptor levels of serum genital hormones, uterine sex hormone and ovarian sex hormone in the androgen-induced anovulatory rats. J Beijing Univ Tradit Chin Med (Chin) 2004,27:24–27.

Song CM, Yang HM, Lu J, Zhou N, Lu S, Duan YC, et al. Effect of Bushen Tiaojing Recipe containing serum on FSH/cAMP-PKA pathway in in vitro cultured human ovarian granular cells. Chin J Integr Med 2014;34:317–323.

Gui YY, Qiu XM, Xu YP, Li DJ, Wang L. Bu-Shen-Ning-Xin Decoction suppresses osteoclastogenesis via increasing dehydroepiandrosterone to prevent postmenopausal osteoporosis. Biosci Trends 2015;3:169–181.

Wang YD, Cui KM, Zhao H, Li DJ, Wang WJ, Zhu Y. Bushen Ningxin Decoction pharmacological serum promotes the proliferation and suppresses the apoptosis of murine osteoblasts through MAPK pathway. J Ethnopharmacol 2009;122:221–226.

Ma K, Liu YF, He JQ, Li M, Shan J. A multi-center, randomized, double-blind clinical study on Bushen Huoxue in treatment of ovulatory dysfunction caused infertility. China J Chin Mater Med 2015;40:3911–3915.

ICH harmonised tripartite guideline: guideline for good clinical practice. J Postgrad Med 2001;47:199–203.

Wu Y, Chen L, Qu F, Sheikh IS, Wu Y. Chinese herbal medicine for premature ovarian failure: a systematic review and meta-analysis. Europ J Integr Med 2014;6:382–391.

Sherman S, Miller H, Nerurkar L, Schiff I. Research opportunities for reducing the burden of menopause-related symptoms. Am J Med 2005;118:166S–171S.

Ried K, Stuart K. Efficacy of traditional Chinese herbal medicine in the management of female infertility: a systematic review. Complement Ther Med 2011;19:319–331.

Wee JJ, Mee PK, eds. Herbal medicine: biomolecular and clinical aspects. Florida: CRC Press;2011.

Ru W, Wang D, Xu Y, He X, Sun YE, Qian L, et al. Chemical constituents and bioactivities of Panax ginseng (C. A. Mey.). Drug Discov Ther 2015;9:23–32.

Duda RB, Taback B, Kessel B, Dooley DD, Yang H, Marchiori J, et al. pS2 expression induced by American ginseng in MCF-7 breast cancer cells. Ann Surg Oncol 1996;3:515–520.

Zhu L, Li J, Xing N, Han D, Kuang H, Ge P. American ginseng regulates gene expression to protect against premature ovarian failure in rats. Biomed Res Int 2015;2015:767124.

Donnapee S, Li J, Yang X, Ge AH, Donkor PO, Gao XM, et al. Cuscuta chinensis Lam.: a systematic review on ethnopharmacology, phytochemistry and pharmacology of an important traditional herbal medicine. J Ethnopharmacol 2014;157:292–308.

Li WL, Ding JX, Zang BS, Gao S, Yang B, Ji YB. Analysis of purified active ingredients of estrogen mimic effect in Cuscuta chinensis by HPLC-Q TOF-MS/MS. Chin Pharmaceut J (Chin) 2014;49:1791–1795.

Pan WH, Xu ZC, Zhao YQ. Research advancement of the pharmacologic action and clinical application of Cuscuta seed. Asia-Pacific Traditional Medicine 2008;4:47–51.

Wang J, Wang M, Ou Y, Wu Q. Effects of flavonoids from Semen Cuscutae on changes of beta-EP in hypothalamuses and FSH and LH in anterior pituitaries in female rats exposed to psychologic stress. J Chin Med Mater 2002;25:886–888.

Cui Y, Yan ZH, Hou SL, Chang ZF. Effect of shu di-huang on the transmitter and receptor of amino acid in brain and learning and memory of dementia model. China J Chin Mater Med (Chin) 2003;28:862–866.

Zhu Y, Xu CH. The bioactive ingredient of Radix Rehmanniae Praeparata and its pharmacological activity. Asia Pacif Tradit Med (Chin) 2011;7:173–175.

Gao J, Inagaki Y, Liu Y. Research progress on flavonoids isolated from traditional Chinese medicine in treatment of Alzheimer's disease. Intractable Rare Dis Res 2013;2:3–10.

Liu J, Burdette JE, Xu H, Gu C, van Breemen RB, Bhat KP, et al. Evaluation of estrogenic activity of plant extracts for the potential treatment of menopausal symptoms. J Agric Food Chem 2001;49:2472–2479.

Pitkin J. Red clover isoflavones in practice: a clinician's view. J Br Menopause Soc 2004;10:7S–12S.

Liang Y, Du HL, Chang XF, Zhao SN, Lei LM. Effect of Bushen Tiaojing Recipe on the quality of the oocytes and reproductive hormones in the follicular fluid in IVF-ET patients. China J Chin Mater Med 2014;34:911–916.

Xu BH, Li MQ, Luo YJ. Treatment of premature ovarian failure patients by Bushen Tiaojing Recipe combined hormone replacement therapy: a clinical observation. Chin J Integr Med 2013;33:1332–1335.

Nian H, Qin LP, Zhang QY, Zheng HC, Yu Y, Huang BK. Antiosteoporotic activity of Er-Xian Decoction, a traditional Chinese herbal formula, in ovariectomized rats. J Ethnopharmacol 2006;108:96–102.

Zhong LL, Tong Y, Tang GW, Zhang ZJ, Choi WK, Cheng KL, et al. A randomized, double-blind, controlled trial of a Chinese herbal formula (Er-Xian Decoction) for menopausal symptoms in Hong Kong perimenopausal women. Menopause 2013;20:767–776.

Sze SC, Tong Y, Zhang YB, Zhang ZJ, Lau AS, Wong HK, et al. A novel mechanism: Erxian Decoction, a Chinese medicine formula, for relieving menopausal syndrome. J Ethnopharmacol 2009;123:27–33.

Li JJ, Li JT, Fu JP. Erxian tang—introduction of a Chinese herbal formula, clinical practice, and experimental studies. Chin J Integr Med 2007;13:67–73.

Zhou J, Qu F. Treating gynaecological disorders with traditional Chinese medicine: a review. Afr J Tradit Complement Altern Med 2009;6:494–517.

Zhou J, Qu F, Sang X, Wang X, Nan R. Acupuncture and auricular acupressure in relieving menopausal hot flashes of bilaterally ovariectomized chinese women: a randomized controlled trial. Evid Based Complement Alternat Med 2011;2011:1–8.

Kim DI, Jeong JC, Kim KH, Rho JJ, Choi MS, Yoon SH, et al. Acupuncture for hot flushes in perimenopausal and postmenopausal women: a randomised, sham-controlled trial. Acupunct Med 2011;29:249–256.

Vincent A, Barton DL, Mandrekar JN, Cha SS, Zais T, Wahner-Roedler DL, et al. Acupuncture for hot flashes: a randomized, sham-controlled clinical study. Menopause 2007;14:45–52.

Kim KH, Kang KW, Kim DI, Kim HJ, Yoon HM, Lee JM, et al. Effects of acupuncture on hot flashes in perimenopausal and postmenopausal women—a multicenter randomized clinical trial. Menopause 2010;17:269–280.

Chang HM, But PPH, eds. Pharmacology and applications of Chinese materia medica (Vol 1). Singapore: World Scientific Publishing Co. Pte. Ltd.;1986.

Niu C, Wang J, Ji L, Wang Z. Protection of Angelica sinensis (Oliv) Diels against hepatotoxicity induced by Dioscorea bulbifera L. and its mechanism. Biosci Trends 2014;8:253–259.

Jin Y, Qu C, Tang Y, Pang H, Liu L, Zhu Z, et al. Herb pairs containing Angelicae Sinensis Radix (Danggui): a review of bio-active constituents and compatibility effects. J Ethnopharmacol 2016;181:158–171.

Powers CN, Setzer WN. A molecular docking study of phytochemical estrogen mimics from dietary herbal supplements. In Silico Pharmacol 2015;3:4–5.

Chen XP, Li W, Xiao XF, Zhang LL, Liu CX. Phytochemical and pharmacological studies on Radix Angelica sinensis. Chin J Nat Med 2013;11:577–587.

FULL TEXT LINK

More>

浏览量

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

Development is a high level inheritance for China Time-honored Brand products

Observation on effects of aconitine via acupoint injection in rabbits

Which research is needed to support clinical decision-making on integrative medicine?—Can comparative effectiveness research close the gap?

Effects and mechanisms of actions of Chinese herbal medicines for asthma

Acupuncture for infertility: Is it an effective therapy?